Affiliation:
1. Department of Biochemistry, Bio-Peak Co., Ltd., 584-70 Shimonojo, Takasaki 370-0854, Japan
2. Biomaterials Research Group, Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba 305-8566, Japan
Abstract
The use of single-domain camelid antibodies, termed VHHs or nanobodies, has found increasing application in diagnosis, pharmaceutical development, and research because of their superior properties, such as small size, elevated stability, high water solubility, and excellent affinity for the antigen. Antigen-specific VHHs are generated by screening VHH display libraries via bio-panning. However, the bio-panning step needs to be repeated multiple times, which is time-consuming and laborious. Here, we developed a simple and rapid screening method that combined Escherichia coli display and a single-step colony assay to successfully identify positive clones from a naïve VHH library. The library was constructed from peripheral blood mononuclear cells of alpaca, and VHHs were displayed on the surface of E. coli using the inverse autotransporter intimin. Libraries enriched by magnetic cell sorting were screened directly using a single-step colony assay. Colonies formed on the hydrophilic filter and antigen-coated membrane. The expression of VHHs was induced, and those bound to the antigen on the membrane were detected as positive clones. Screening and identification of positive clones required only two days, which saves considerable time and resources compared to existing protocols.
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference52 articles.
1. Building better monoclonal antibody-based therapeutics;Weiner;Nat. Rev. Cancer,2015
2. Engineered antibody fragments and the rise of single domains;Holliger;Nat. Biotechnol.,2005
3. Microbials for the production of monoclonal antibodies and antibody fragments;Spadiut;Trends Biotechnol.,2013
4. Sandomenico, A., Sivaccumar, J.P., and Ruvo, M. (2020). Evolution of Escherichia coli expression system in producing antibody recombinant fragments. Int. J. Mol. Sci., 21.
5. scFv Antibody: Principles and clinical application;Ahmad;J. Immunol. Res.,2012